Clinical Trial: LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis

U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06427720) titled 'LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis' on May 20.

Brief Summary: Breast cancer is a leading cause of death among women globally, with significant incidence in Egypt. It is characterized by aggressive behavior and resistance to treatment, necessitating early detection methods. Research has revealed that many cancer-related mutations are in non-coding DNA, including microRNAs (miRNAs) and long non-coding RNAs (LncRNAs). miRNAs like miR-185-3p and miR-301a, and LncRNAs such as LINC00511, are potential biomarkers for cancer diagnosis due to their roles in gene regulation and stability in circulatio...